Skip to main content
Pathology and Oncology Research logoLink to Pathology and Oncology Research
. 2024 Mar 21;30:1611758. doi: 10.3389/pore.2024.1611758

Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

Peter Batar 1,*, Hussain Alizadeh 2, Gyorgy Rokszin 3, Zsolt Abonyi-Toth 3,4, Judit Demeter 5
PMCID: PMC10991778  PMID: 38576767

In the published article, there was an error in the Funding statement. It originally stated:

“The authors declare that this study received funding from Pfizer. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.”

The Funding statement has now been removed.

In the published article, there was an error in the Conflict of interest Statement. It originally stated:

“Authors GR and ZA-T were employed by RxTarget Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The correct Conflict of interest statement appears below.

“GR and ZA-T are employees of RxTarget Ltd., which was a paid contractor to Pfizer in connection with the development of this manuscript and was responsible for data curation and statistical analysis. This study was sponsored by Pfizer. Medical writing support was provided by Zsófia Barcza at Syntesia Medical Communications Ltd. and was funded by Pfizer. The funder had the following involvement in the study: administrative support and review regarding study design, statistical analysis, and manuscript development.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Pathology and Oncology Research are provided here courtesy of Frontiers Media SA

RESOURCES